4.7 Review

Plasticizers and Cardiovascular Health: Role of Adipose Tissue Dysfunction

Journal

FRONTIERS IN PHARMACOLOGY
Volume 11, Issue -, Pages -

Publisher

FRONTIERS MEDIA SA
DOI: 10.3389/fphar.2020.626448

Keywords

bisphenols (BPs); phthalates (PAEs); adipogenesis; adipose tissue; cardiovascular disease

Funding

  1. Libin Cardiovascular Institute
  2. Graduate Scholarship in Women's Cardiovascular Health
  3. Kertland Fellowship
  4. National Sciences and Engineering Research Council of Canada (NSERC)
  5. Alberta Children's Hospital Research Institute (ACHRI)

Ask authors/readers for more resources

The production of plastics has dramatically increased since the 1950s, leading to concerns over the potential health risks associated with plasticizers, commonly found in food and beverages. Studies have shown that exposure to plasticizers may increase the risk for obesity, type 2 diabetes, and cardiovascular disease. Governments have implemented restrictions on certain plasticizers in products for infants and children, prompting manufacturers to seek safer alternatives. However, limited data on the effects of these substitutes suggest that they may pose similar risks as the chemicals they replaced.
Since the 1950s, the production of plastics has increased 200-fold, reaching 360 million tonnes in 2019. Plasticizers, additives that modify the flexibility and rigidity of the product, are ingested as they migrate into food and beverages. Human exposure is continuous and widespread; between 75 and 97% of urine samples contain detectable levels of bisphenols and phthalates, the most common plasticizers. Concern over the toxicity of plasticizers arose in the late 1990s, largely focused around adverse developmental and reproductive effects. More recently, many studies have demonstrated that exposure to plasticizers increases the risk for obesity, type 2 diabetes, and cardiovascular disease (CVD). In the 2000s, many governments including Canada, the United States and European countries restricted the use of certain plasticizers in products targeted towards infants and children. Resultant consumer pressure motivated manufacturers to substitute plasticizers with analogues, which have been marketed as safe. However, data on the effects of these new substitutes are limited and data available to-date suggest that many exhibit similar properties to the chemicals they replaced. The adverse effects of plasticizers have largely been attributed to their endocrine disrupting properties, which modulate hormone signaling. Adipose tissue has been well-documented to be a target of the disrupting effects of both bisphenols and phthalates. Since adipose tissue function is a key determinant of cardiovascular health, adverse effects of plasticizers on adipocyte signaling and function may underlie their link to cardiovascular disease. Herein, we discuss the current evidence linking bisphenols and phthalates to obesity and CVD and consider how documented impacts of these plasticizers on adipocyte function may contribute to the development of CVD.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available